GenVec, Inc. GNVC announced that Adel A.F. Mahmoud, M.D., Ph.D. and Edward M. Connor, Jr., M.D. were elected to the Company's Board of Directors at its annual meeting of stockholders held on June 15, 2011.
"Drs. Mahmoud and Connor bring a wealth of experience, especially in infectious disease and vaccine development, to GenVec. As we expand the breadth and scope of our vaccine programs there is no substitute for the knowledge that comes from the successful introduction of new products into the marketplace," said Dr. Paul Fischer, GenVec's President and Chief Executive Officer.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in